GeneIQ is a molecular diagnostics laboratory focused on providing a multi-faceted PCR Infectuous disease testing portfolio. Additionaly, our GeneIQ pharmacogenomic platform can determine how a patient's genetic makeup will affect response to numerous medications prescribed in a number of specialties including addiction, cardiology, diabetes, gastroenterology, neurology, oncology, orthopedics, pain management, psychiatry, and rheumatology. With 27 different genes and 10 test menus available for analysis, GeneIQ provides the most robust pharmacogenetic offering to clinicians. We combine the expertise of an outstanding laboratory team combined with a nationally renowned scientific team. Our robust process and state of the art instrument methodology ensures expedited delivery of results and the highest level of patient support.